Myasthenia gravis, or MG, is "a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue," says Hesterlee. It occurs "when a person’s immune system is essentially attacking ...

This week we are going to discuss a neurological auto-immune condition that affects older patients but can even affect younger patients—Generalized Myasthenia Gravis. Unlike demyelinating diseases of ...

The National Institutes of Health (NIH) awarded a research team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. The network, which will ...

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...

In recent years, five other drugs have been approved to treat gMG, including three complement inhibitors -- eculizumab ...

Dear Doctors: Can you please talk about myasthenia gravis? Our oldest daughter has been diagnosed with it. She’s 33 and lives with her family in another state, but we want to understand what she’s ...

Study findings show eculizumab is effective and well tolerated in reducing disease burden in adolescents with refractory anti-acetylcholine receptor antibody–positive generalized myasthenia gravis.

SOME understanding of both the problems of diagnosis and the pathophysiology of myasthenia gravis should precede a discussion of modern technics of therapy. Myasthenia gravis is still a rare condition ...

Medically reviewed by Diana Apetauerova, MD Key Takeaways Weakness in the legs can be a sign of serious health issues like ...

Johnson & Johnson has received European Commission approval for nipocalimab, marketed as IMAAVY, as an add-on therapy for ...

Dear Doctors: Can you please talk about myasthenia gravis? Our oldest daughter has been diagnosed with it. She's 33 and lives with her family in another state, but we want to understand what she's ...